ENGN Stock Summary and Trading Ideas (Engene Therapeutics | NASDAQ:ENGN)

enGene Therapeutics Inc is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, to create new ways to address diseases with high clinical needs. Its pioneering program is detalimogene voraplasmid (also known as detalimogene) for patients with Non-Muscle Invasive Bladder Cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase 2 trial, which includes a pivotal cohort studying detalimogene in high-risk, Bacillus Calmette-Guerin (BCG)-unresponsive patients with carcinoma in situ (CIS) with or without concomitant papillary disease. It is developed using enGene's proprietary Dually Derivatized Oligochitosan (DDX) platform.

What symbol and exchange does Engene Therapeutics shares trade?

Engene Therapeutics trades on the NASDAQ stock market under the symbol ENGN.

What is Engene Therapeutics stock price doing today?

As of August 28, 2026, ENGN stock price declined to $1.83 with 441,428 million shares trading.

What is Engene Therapeutics's Beta?

ENGN has a beta of 0.33, meaning it tends to be less sensitive to market movements. ENGN has a correlation of 0.00 to the broad based SPY ETF.

How much is Engene Therapeutics worth?

ENGN has a market cap of $122.25 million. This is considered a Micro Cap stock.

Is Engene Therapeutics (ENGN) a good investment?

ENGN has underperformed the market in the last year with a return of -61.6%, while SPY returned +19.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ENGN shares. However, ENGN has outperformed the market in the last 3 month and 2 week periods, returning +2.5% and +7.4%, while SPY returned +2.2% and -0.9%, respectively. This indicates ENGN has been having a stronger performance recently.

What are the support and resistance levels for Engene Therapeutics (ENGN)?

ENGN support price is $1.85 and resistance is $1.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ENGN shares will trade within this expected range on the day.